These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33811609)
1. Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men. Sansone A; Kliesch S; Dugas M; Sandhowe-Klaverkamp R; Isidori AM; Schlatt S; Zitzmann M J Endocrinol Invest; 2021 Nov; 44(11):2465-2474. PubMed ID: 33811609 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism? Di Luigi L; Sgrò P; Fierro V; Bianchini S; Battistini G; Magini V; Jannini EA; Lenzi A J Sex Med; 2010 Jul; 7(7):2591-601. PubMed ID: 20141589 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency. McMahon CG; Shusterman N; Cohen B J Sex Med; 2017 Jul; 14(7):883-890. PubMed ID: 28673432 [TBL] [Abstract][Full Text] [Related]
4. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction. Yassin AA; Nettleship JE; Salman M; Almehmadi Y Andrologia; 2017 May; 49(4):. PubMed ID: 27400881 [TBL] [Abstract][Full Text] [Related]
5. Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels. Gooren LJ; Saad F; Haide A; Yassin A Andrologia; 2008 Oct; 40(5):298-302. PubMed ID: 18811920 [TBL] [Abstract][Full Text] [Related]
6. The impact of age, BMI and sex hormone on aging males' symptoms and the international index of erectile function scores. Yu XH; Zhao J; Zhang SC; Li JH; Zheng JB; Li Z; Liang GQ; Shi HJ; Zhou WJ; Zhu QX Aging Male; 2017 Dec; 20(4):235-240. PubMed ID: 28780904 [TBL] [Abstract][Full Text] [Related]
7. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Almehmadi Y; Yassin DJ; Yassin AA Aging Male; 2015; 18(3):186-94. PubMed ID: 26030350 [TBL] [Abstract][Full Text] [Related]
8. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222 [TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Kapoor D; Aldred H; Clark S; Channer KS; Jones TH Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140 [TBL] [Abstract][Full Text] [Related]
11. Association of hypogonadism symptoms and serum hormones in aging males. Liang G; Song Y; Liu L; Zhou K; Tian J; Li J; Shi H; Zhu Q; Wang J; Zheng J; Yu X; Zhang S; Li Z; Liu X Andrologia; 2021 Jun; 53(5):e14013. PubMed ID: 33599350 [TBL] [Abstract][Full Text] [Related]
13. Testosterone levels in men with erectile dysfunction. Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726 [TBL] [Abstract][Full Text] [Related]
14. Transdermal testosterone therapy in the treatment of male hypogonadism. Ahmed SR; Boucher AE; Manni A; Santen RJ; Bartholomew M; Demers LM J Clin Endocrinol Metab; 1988 Mar; 66(3):546-51. PubMed ID: 3350906 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic criteria for late-onset hypogonadism: A preliminary study]. DU JP; Li FP; Zheng XB; Lan BY; Lin DZ; Li Y; Yan L Zhonghua Nan Ke Xue; 2016 Nov; 22(11):979-983. PubMed ID: 29281204 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial. Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Corona G; Rastrelli G; Morgentaler A; Sforza A; Mannucci E; Maggi M Eur Urol; 2017 Dec; 72(6):1000-1011. PubMed ID: 28434676 [TBL] [Abstract][Full Text] [Related]
19. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism. Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990 [TBL] [Abstract][Full Text] [Related]
20. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints. Permpongkosol S; Tantirangsee N; Ratana-olarn K J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]